boron and Lymphoma--Mantle-Cell

boron has been researched along with Lymphoma--Mantle-Cell* in 1 studies

Other Studies

1 other study(ies) available for boron and Lymphoma--Mantle-Cell

Article	Year
Boronic esters in asymmetric synthesis. The Journal of organic chemistry, 2013, Oct-18, Volume: 78, Issue:20 The author's work on (α-haloalkyl)boronic esters as reagents for asymmetric synthesis is reviewed. Diastereomeric ratios exceeding 1000 can be achieved with this chemistry, and ratios around 100 are commonplace. The method allows sequential installation of a series of stereocenters and tolerates a wide variety of suitably protected functional substituents. (α-Amidoalkyl)boronic acids include biochemically significant serine protease inhibitors, one of which is the clinically successful proteasome inhibitor bortezomib, used for treatment of multiple myeloma and mantle cell lymphoma. Topics: Amines; Antineoplastic Agents; Boron; Boronic Acids; Esters; Indicators and Reagents; Lymphoma, Mantle-Cell; Molecular Structure; Multiple Myeloma; Protease Inhibitors	2013

Article

Year

The Journal of organic chemistry, 2013, Oct-18, Volume: 78, Issue:20

The author's work on (α-haloalkyl)boronic esters as reagents for asymmetric synthesis is reviewed. Diastereomeric ratios exceeding 1000 can be achieved with this chemistry, and ratios around 100 are commonplace. The method allows sequential installation of a series of stereocenters and tolerates a wide variety of suitably protected functional substituents. (α-Amidoalkyl)boronic acids include biochemically significant serine protease inhibitors, one of which is the clinically successful proteasome inhibitor bortezomib, used for treatment of multiple myeloma and mantle cell lymphoma.

Topics: Amines; Antineoplastic Agents; Boron; Boronic Acids; Esters; Indicators and Reagents; Lymphoma, Mantle-Cell; Molecular Structure; Multiple Myeloma; Protease Inhibitors

2013